Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.32
- Piotroski Score 4.00
- Grade Neutral
- Symbol (ALBO)
- Company Albireo Pharma, Inc.
- Price $44.15
- Changes Percentage (0%)
- Change -$0
- Day Low $44.00
- Day High $44.90
- Year High $45.23
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-threatening disorder to children; and Elobixibat for the treatment of chronic constipation and other functional diseases. It also engages in the developing of A3907, which is in Phase I clinical trial for the treatment of adult liver diseases; and A2342, a preclinical candidate to treat adult viral and liver diseases. The company has a license agreement with EA Pharma Co., Ltd. for the development and commercialization of elobixibat. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 05/15/2023
- Fiscal Year End N/A
- Average Stock Price Target $42.00
- High Stock Price Target $48.00
- Low Stock Price Target $42.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$6.66
- Trailing P/E Ratio -6.6291291291291
- Forward P/E Ratio -6.6291291291291
- P/E Growth -6.6291291291291
- Net Income $-151,349,000
Income Statement
Quarterly
Annual
Latest News of ALBO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
What Happened To Alex Albon? Video Footage Emerges Of Azerbaijan Chaos
During Azerbaijan Grand Prix Qualifying, a Williams mechanic narrowly avoided injury when almost hit by Alex Albon's car due to an error in releasing it with a fan attached....
By Newsweek | 2 weeks ago -
Port Talbot job losses: what's next for British steel production?
Labour's ongoing plan for the steel industry faces challenges as Port Talbot's rescue package won't prevent closure of blast furnaces and job losses. The decline of primary steel-making in Britain rai...
By The Guardian | 2 weeks ago -
Labour's plan for steel is a work in progress. Port Talbot was almost the easy part | Nils Pratley
The owner of British Steel is considering closing its blast furnaces in Scunthorpe, potentially leading to a crisis. Despite challenges, the UK steel industry's future relies on strategic decisions an...
By The Guardian | 2 weeks ago
